Put Pharmacogenetic Testing for Mental Health Meds Into Perspective

October 2018

You'll hear debate about using pharmacogenetic testing to guide treatment for depression, ADHD, and other mental health conditions.

Some pharmacies are getting involved in performing these tests...or using results to tailor med recommendations and educate patients.

The goal of testing is to identify gene variations that may predict how a patient responds to certain meds.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Influenza Emphasize Influenza Immunization for 2018-19
Epinephrine Be Ready for Questions About EpiPen Shortages and Auvi-Q
Diabetes Know Where Basal Insulin Combo Products Fit In to Diabetes Management
Cardiology Address Depression in Patients After a Heart Attack
Migraine Put New Aimovig for Migraine Prophylaxis Into Perspective
Pharmacogenetics Put Pharmacogenetic Testing for Mental Health Meds Into Perspective
Dermatology Help Get to the Bottom of Diaper Rash
Pregnancy Weigh the Risks and Benefits to Decipher Med Safety in Pregnancy
Natural Medicines Focus on Safety if Patients Use Essential Oils
HIV & AIDS Expect Integrase Inhibitors to Gain an Edge in Treating HIV
Antithrombotics Consider Lower Doses of Oral Anticoagulation With Aspirin Plus Clopidogrel
Practice Remember "Cooler Heads Prevail" When Conflict Arises